Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study.
Civan C, Kasper S, Berliner C, Fragoso-Costa P, Grünwald V, Pogorzelski M, Schaarschmidt BM, Lang S, Kersting D, Nader M, Lückerath K, Herrmann K, Fendler WP, Weber M. Civan C, et al. Among authors: grunwald v. J Nucl Med. 2023 Mar;64(3):372-378. doi: 10.2967/jnumed.122.264342. Epub 2022 Sep 22. J Nucl Med. 2023. PMID: 36137757 Free PMC article.
Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP.
Folprecht G, Trautmann K, Stein A, Huebner G, Stahl M, Kasper S, Kretzschmar A, Köhne CH, Grünwald V, Hofheinz RD, Schütte K, Löffler H, Bokemeyer C, Krämer A; Arbeitsgemeinschaft Internistische Onkologie (AIO) - CUP Group. Folprecht G, et al. Among authors: grunwald v. Br J Cancer. 2021 Feb;124(4):721-727. doi: 10.1038/s41416-020-01141-8. Epub 2020 Nov 25. Br J Cancer. 2021. PMID: 33235314 Free PMC article. Clinical Trial.
Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy.
Ferdinandus J, Metzenmacher M, Kessler L, Umutlu L, Aigner C, Karl KO, Grünwald V, Eberhardt W, Fendler WP, Herrmann K, Faehling M, Christoph DC. Ferdinandus J, et al. Among authors: grunwald v. J Immunother Cancer. 2021 Mar;9(3):e002262. doi: 10.1136/jitc-2020-002262. J Immunother Cancer. 2021. PMID: 33789880 Free PMC article.
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab.
Pogorzelski M, Hilser T, Ting SC, Kansy B, Gauler TC, Stuschke M, Schmid KW, Lang S, Grünwald V, Schuler M, Kasper S. Pogorzelski M, et al. Among authors: grunwald v. Front Oncol. 2021 May 13;11:635096. doi: 10.3389/fonc.2021.635096. eCollection 2021. Front Oncol. 2021. PMID: 34055606 Free PMC article.
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma.
Ferdinandus J, Zaremba A, Zimmer L, Umutlu L, Seifert R, Barbato F, Ugurel S, Chorti E, Grünwald V, Herrmann K, Schadendorf D, Fendler WP, Livingstone E. Ferdinandus J, et al. Among authors: grunwald v. Cancer Imaging. 2022 Feb 5;22(1):11. doi: 10.1186/s40644-022-00449-3. Cancer Imaging. 2022. PMID: 35123578 Free PMC article.
FDG-PET Positivity and Overall Survival in Renal Cell Carcinoma.
Ferdinandus J, Maríc I, Darr C, Kesch C, Bartel T, Fendler WP, Grünwald V. Ferdinandus J, et al. Among authors: grunwald v. JAMA Netw Open. 2022 Nov 1;5(11):e2242289. doi: 10.1001/jamanetworkopen.2022.42289. JAMA Netw Open. 2022. PMID: 36383385 Free PMC article.
264 results